Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfister

Showing results (561-570 of 666) with videos related to

Pageof 67
Sort By:
Developmental Cell|March 20, 2018
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH MedulloblastomaDaniel J Merk, Jasmin Ohli, Natalie D Merk, et al.
Cell|May 28, 2013
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongationGabriel Leprivier, Marc Remke, Barak Rotblat, et al.
Cancer Cell|May 16, 2025
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic targetShiekh Tanveer Ahmad, Yiran Li, Jesus Garcia-Lopez, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2019
Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experienceElke Pfaff, Ahmed El Damaty, Gnana Prakash Balasubramanian, et al.
Neuro-Oncology|March 12, 2025
Germline analysis of an international cohort of pediatric diffuse midline glioma patientsMarion K Mateos, Pamela Ajuyah, Noemi Fuentes-Bolanos, et al.
Neuro-Oncology|November 18, 2024
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimensAnna Laemmerer, Christian Lehmann, Lisa Mayr, et al.
Acta Neuropathologica Communications|October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entitiesAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Cancer Cell|September 12, 2018
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic ProfilingAntoine Forget, Loredana Martignetti, Stéphanie Puget, et al.
Neuro-Oncology|June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all AgesAbigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
Pageof 67

Showing results (561-570 of 666) with videos related to

Sort By:
Pageof 67
Developmental Cell|March 20, 2018
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH MedulloblastomaDaniel J Merk, Jasmin Ohli, Natalie D Merk, et al.
Cell|May 28, 2013
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongationGabriel Leprivier, Marc Remke, Barak Rotblat, et al.
Cancer Cell|May 16, 2025
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic targetShiekh Tanveer Ahmad, Yiran Li, Jesus Garcia-Lopez, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2019
Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experienceElke Pfaff, Ahmed El Damaty, Gnana Prakash Balasubramanian, et al.
Neuro-Oncology|March 12, 2025
Germline analysis of an international cohort of pediatric diffuse midline glioma patientsMarion K Mateos, Pamela Ajuyah, Noemi Fuentes-Bolanos, et al.
Neuro-Oncology|November 18, 2024
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimensAnna Laemmerer, Christian Lehmann, Lisa Mayr, et al.
Acta Neuropathologica Communications|October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entitiesAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Cancer Cell|September 12, 2018
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic ProfilingAntoine Forget, Loredana Martignetti, Stéphanie Puget, et al.
Neuro-Oncology|June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all AgesAbigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
Pageof 67